IMMUNOHEMATOLOGY CHAPTER 20 - HDFN Flashcards

1
Q

Who reported a transfusion reaction during 1939

A

Levine and Stetson

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Maternal RBC alloimmunization can be caused by

A

previous pregnancy or previous transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Only antibodies of the
immunoglobulin ——– class are actively transported
across the placenta via Fc receptors

A

G (IgG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the most common cause of HDFN

A

ABO incompatibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ABO antibodies are present in
the plasma of all individuals whose RBCs lack the corresponding antigen. These antibodies, also called ——— result from environmental stimulus in early life

A

isohemagglutinins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

group —– individuals are most likely to form high-titered IgG anti-ABO antibodies

A

O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

————- and ————– during pregnancy have been linked to the production of high-titered IgG ABO antibodies and severe HDFN

A

Tetanus toxoid administration,
helminth parasite infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

causes a bilirubin peak at 1 to 3 days
a. ABO HDFN
b. RhD HDFN

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

First pregnancy can be
affected
a. ABO HDFN
b. RhD HDFN
c. both

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Disease predicted by titers
a. ABO HDFN
b. RhD HDFN
c. both

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causative antibody IgG
a. ABO HDFN
b. RhD HDFN
c. both

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Elevated bilirubin level at birth
a. ABO HDFN
b. RhD HDFN
c. both

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Intrauterine transfusion
needed
a. ABO HDFN
b. RhD HDFN
c. both

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anemia at birth
a. ABO HDFN
b. RhD HDFN
c. both

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phototherapy beneficial
a. ABO HDFN
b. RhD HDFN
c. both

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exchange transfusion needed (rare)
a. ABO HDFN
b. RhD HDFN
c. both

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Interventions such as —————– to the abdomen can increase the risk of
FMH.

A

amniocentesis and chorionic villus
sampling and trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The active transport of IgG begins in ———– and continues until birth

A

the second trimester

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The IgG molecules are transported via the
—– portion of the antibodies

A

Fc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

more efficient in RBC intravascular hemolysis
a. IgG 1 and IgG 2
b. IgG 2 and IgG 4
c. IgG 1 and IgG 3
d. IgG 3 and IgG 4

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

most antigenic RBC antigen

A

RhD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The common antigens in the Rh system ———- are also potent immunogens and have been associated with moderate to severe cases of HDFN

A

(C, E, and c)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antiges which cause severe HDFN that required intervention and
treatment.

A

Anti-E
Anti-c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Of the non–Rh system antibodies, _____ is considered as the most clinically significant in its ability to cause HDFN.

A

anti-Kell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

_____________ antigens are present on immature erythroid cells in the fetal bone marrow, so severe anemia occurs not only by destruction of circulating RBCs but also by destruction of precursors.

A

Kell blood group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Antibodies Identified in
Prenatal Specimens That Can Cause of HDFN

Anti Lea

a. common
b. rare
c. never

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Antibodies Identified in
Prenatal Specimens That Can Cause of HDFN

Anti Leb

a. common
b. rare
c. never

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Antibodies Identified in
Prenatal Specimens That Can Cause of HDFN

Anti M

a. common
b. rare
c. never

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Antibodies Identified in
Prenatal Specimens That Can Cause of HDFN

Anti Jka

a. common
b. rare
c. never

A

b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Antibodies Identified in
Prenatal Specimens That Can Cause of HDFN

Anti D+C

a. common
b. rare
c. never

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

When the mother is ABO-incompatible with the fetus (major incompatibility), the incidence of detectable fetomaternal hemorrhage is ———-.

A

decreased

32
Q

——— occurs when maternal IgG attaches to specific antigens of the fetal RBCs.

A

Hemolysis

33
Q

The antibody-coated cells are removed
from the circulation by the macrophages of the ——

A

fetal spleen

34
Q

Destruction of fetal RBCs and the resulting anemia stimulate the fetal bone marrow to produce RBCs at an accelerated rate, even to the point that immature RBCs (erythroblasts) are released into the circulation

A

erythroblastosis fetalis

35
Q

Severe anemia and hypoproteinemia caused by decreased hepatic production of plasma proteins leads to the development of high-output cardiac failure with generalized edema,
effusions, and ascites, a condition known as ———–

A

hydrops fetalis.

36
Q

In severe cases, hydrops fetalis can develop by ——— gestation.

A

18 to 20 weeks’

37
Q

What is IgG’s half-life

A

25 days

38
Q

3 different phases of anemia caused by HDFN

A
  1. Early (within 7 days of birth) due to antibody-mediated hemolysis
  2. late hemolytic anemia (2 weeks or
    more after birth) due to continued hemolysis, the expanding intravascular compartment, and natural decline of hemoglobin levels
  3. late hyporegenerative (2 weeks or
    more after birth) anemia due
    to marrow suppression as a result of transfusions and IUT,
    antibody destruction of RBC precursors, and deficiency of
    erythropoietin
39
Q

RBC destruction releases hemoglobin, which is metabolized
to ——

A

bilirubin

40
Q

unconjugated and does not dissolve in water
a. direct bilirubin
b. indirect bilirubin

A

b

41
Q

It travels through the bloodstream to the liver to be conjugated and
rendered water soluble and is excreted
through the gastrointestinal tract.
a. direct bilirubin
b. indirect bilirubin

A

a

42
Q

The ——— is not
able to metabolize the indirect bilirubin

A

fetal liver

43
Q

With moderate to severe hemolysis of HDFN, the unconjugated, or indirect, bilirubin can reach levels toxic to the infant’s brain (generally, more than ———–),
and if left untreated can cause ——— or permanent damage to the brain.

A

18 to 20 mg/dL
kernicterus

44
Q

Consequently,
detection of ABO HDFN is best done
a. before birth
b. after birth

A

after birth

45
Q

On the other hand, the DAT result can be positive even in the absence of signs and symptoms of clinical anemia in the newborn infant.
TRUE or FALSE

A

true

46
Q

If the neonatal infant develops jaundice, ———— testing can be carried out and the results can be assessed

A

ABO, RhD, and DAT

47
Q

For tube testing, an
antibody-enhancing medium such as —————————— can increase sensitivity of the assay

A

polyethylene glycol
(PEG) or low ionic strength solution (LISS)

48
Q

—— system antibodies are rather common in pregnant women but have not been reported to cause HDFN.

A

Lewis

49
Q

To establish the immunoglobulin
class, the serum can be treated with a ——- reagent. The J-chain of —- antibodies will be destroyed by this treatment; —– antibodies
will remain reactive.

A

sulfhydryl
IgM
IgG

50
Q

How many weeks gestation is antenatal

A

28 weeks

51
Q

Many Rh-negative pregnant women have weakly reactive anti-D, particularly during the ———-

A

third trimester

52
Q

A titer higher than ____ almost always indicates active immunization

A

4

53
Q

If encountering a sample from a pregnant patient, using ______ appears to provide the least number of false positives compared to gel cards and solid phase

A

PEG

54
Q

The relative concentration of all antibodies capable of crossing the placenta and causing HDFN is determined by ______________

A

antibody titration

55
Q

recommended method for antibody titer

A

saline antiglobulin tube test, with 60-minute
incubation at 37°C and the use of anti-IgG reagent

56
Q

For the recommended method, ___ is considered the critical titer.

A

16

57
Q

If the initial titer is 16 or higher, a second titer
should be done at about ______ weeks’ gestation

A

18 to 20

58
Q

When the titer is less than 30, it should be repeated at 4-week intervals, beginning at 16 to 20 weeks’ gestation and then every 2 to 4 weeks during the third trimester

TRUE OR FALSE

A

fasle, should be 32 instead of 30

59
Q

A specimen of the ______’s blood should be obtained and tested for the presence and zygosity (predicted copy number of the gene) of the corresponding blood group antigen to predict fetal risk of being affected by HDFN.
a. mother
b. father

A

b

60
Q

the recommended test for RhD-positive fathers when the mother has anti-D antibody

A

zygosity genotype testing

61
Q

Risk stratification of the fetus can be directly carried out by obtaining fetal cells through ——– or —————- as early as ————-’ gestation.

A

amniocentesis chorionic
villous sampling (CVS)
10 to 12 weeks

62
Q

At about ———— gestation, the clinical diagnosis of fetal anemia can be made using an ultrasound technique called fetal middle cerebral artery peak systolic velocity (MCA-PSV)

A

16 to 20 weeks’

63
Q

In middle cerebral artery peak systolic velocity
(MCA-PSV), the measurement is based on the
————— at ————— and resulting in faster velocity of the blood.
a. reduced blood viscosity, lower hematocrits
b. increased blood viscosity, higher hematocrits

A

a

64
Q

When fetal anemia becomes moderate to severe as indicated by Doppler MoM measurements exceeding 1.5, invasive testing via ————– is done to determine fetal hematocrit

A

cordocentesis

65
Q

If the fetus has not reached an acceptable gestational age for delivery, and the hematocrit level is less than 30%, —————– is usually indicated.

A

intrauterine transfusion

66
Q

Intervention in the form of intrauterine transfusion becomes necessary when one or more of the following conditions exists:

A
  • MCA-PSV indicates anemia (>1.5 MoM).
  • Fetal hydrops is noted on ultrasound examination.
  • Cordocentesis blood sample has hemoglobin level less than 10 g/dL.
  • Amniotic fluid ∆OD 450 nm results are high and/or increasing.
67
Q

The goal of intrauterine transfusion is to maintain fetal hemoglobin above ———

A

10 g/dL

68
Q

The RBC unit is irradiated to prevent transfusion-associated ———–

A

graft-versus-host disease

69
Q

Rarely, the infant’s RBCs can be heavily antibody-bound with maternal anti-D, causing a false-negative Rh type, or what has been called as ——–

A

blocked Rh

70
Q

The most important serologic test for diagnosing HDFN is

A

DAT with anti-IgG reagent

71
Q

Phototherapy at ———- is used to metabolize the unconjugated bilirubin to isomers that are less lipophilic, less toxic to the brain, and able to be excreted through urine.

A

460 to 490 nm

72
Q

—————- is used to treat hyperbilirubinemia of the newborn caused by HDFN.

A

Intravenous immune globulin (IVIG)

73
Q

In the Kleihauer-Betke test, a maternal blood smear is treated with acid and then stained with counterstain. Fetal cells contain fetal hemoglobin (Hgb F), which is resistant to acid and will remain ——- The maternal cells will appear as ——-

A

pink, ghost

74
Q

Prenatal serologic tests for obstetric patients include an ABO, Rh, and antibody screen during the first __________.

A

trimester of pregnancy.

75
Q

RhIG administered to the mother within ___ hours
following delivery is used to prevent active immunization by the RhD antigen on fetal cells

A

72

76
Q

A __________ test or flow cytometry is used to
quantitate the number of fetal RhD-positive cells in the mother’s circulation as a result of a fetomaternal hemorrhage.

A

Kleihauer-Betke